Connor, Clark & Lunn Investment Management (CC&L)
CHE icon

Connor, Clark & Lunn Investment Management (CC&L)’s Chemed CHE Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio CHE Stock Details CHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.02M Sell
2,186
-766
-26% -$322K ﹤0.01% 1189
2026
Q1 		$1.12M Buy
2,952
+1,621
+122% +$694K ﹤0.01% 1132
2025
Q4 		$569K Sell
1,331
-256
-16% -$111K ﹤0.01% 1275
2025
Q3 		$711K Sell
1,587
-4,557
-74% -$2.06M ﹤0.01% 1168
2025
Q2 		$2.99M Buy
+6,144
New +$3.5M 0.01% 734
2025
Q1 		– Sell
-2,242
Closed -$1.19M – 1432
2024
Q4 		$1.19M Sell
2,242
-4,140
-65% -$2.33M 0.01% 872
2024
Q3 		$3.84M Buy
+6,382
New +$3.62M 0.02% 503
2022
Q3 		– Sell
-1,144
Closed -$537K – 1123
2022
Q2 		$537K Buy
+1,144
New +$558K ﹤0.01% 757
2022
Q1 		– Sell
-448
Closed -$237K – 1061
2021
Q4 		$237K Sell
448
-5,878
-93% -$2.82M ﹤0.01% 938
2021
Q3 		$2.94M Sell
6,326
-19,889
-76% -$9.38M 0.02% 447
2021
Q2 		$12.4M Buy
26,215
+43
+0.2% +$20.6K 0.06% 215
2021
Q1 		$12M Buy
26,172
+254
+1% +$125K 0.07% 202
2020
Q4 		$13.8M Sell
25,918
-3,509
-12% -$1.72M 0.08% 189
2020
Q3 		$14.1M Buy
29,427
+1,008
+4% +$494K 0.09% 164
2020
Q2 		$12.8M Buy
28,419
+8,629
+44% +$3.85M 0.09% 175
2020
Q1 		$8.57M Buy
19,790
+7,400
+60% +$3.3M 0.08% 185
2019
Q4 		$5.44M Buy
12,390
+7,765
+168% +$3.27M 0.04% 262
2019
Q3 		$1.93M Buy
4,625
+3,675
+387% +$1.5M 0.01% 420
2019
Q2 		$343K Buy
950
+250
+36% +$83.6K ﹤0.01% 798
2019
Q1 		$224K Sell
700
-275
-28% -$84.5K ﹤0.01% 807
2018
Q4 		$276K Sell
975
-3,525
-78% -$1.06M ﹤0.01% 800
2018
Q3 		$1.44M Buy
4,500
+2,500
+125% +$797K 0.01% 499
2018
Q2 		$644K Buy
+2,000
New +$626K ﹤0.01% 713
2014
Q4 		– Sell
-4,900
Closed -$504K – 589
2014
Q3 		$504K Buy
4,900
+2,600
+113% +$263K ﹤0.01% 389
2014
Q2 		$230K Hold
2,300
– – ﹤0.01% 476
2014
Q1 		$227K Sell
2,300
-200
-8% -$16.3K ﹤0.01% 603
2013
Q4 		$204K Buy
+2,500
New +$184K ﹤0.01% 662

Other funds holding CHE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s CHE Position: Q2 2026 in Review

Connor, Clark & Lunn Investment Management (CC&L) reduced its Chemed (CHE) stake by 26% in Q2 2026, selling an estimated $322K and leaving 2,186 shares worth $1.02M. The position accounts for ﹤0.01% of the portfolio, ranked #1189.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in CHE in Q4 2013 and has held it in 27 quarters since. The position peaked at $14.1M in Q3 2020. 530 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

  • Connor, Clark & Lunn Investment Management (CC&L) held 2,186 shares of Chemed worth $1.02M as of Q2 2026.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 766 Chemed shares in Q2 2026, an estimated $322K.
  • Chemed made up ﹤0.01% of Connor, Clark & Lunn Investment Management (CC&L)'s portfolio in Q2 2026, its #1189 holding.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Chemed in Q4 2013 and has held it in 27 quarters since.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Chemed position peaked at $14.1M in Q3 2020.
  • 530 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2026, filed 13 Aug 2026.